Mortality and cost associated with cardiovascular implantable electronic device infections

Archives of Internal Medicine

Volumn 171, Issue 20, 2011, Pages 1821-1828

  Sohail, Muhammad R ^a   Henrikson, Charles A ^b   Braid Forbes, Mary Jo ^c   Forbes, Kevin F ^c,d   Lerner, Daniel J ^e  

^a Mayo Clinic   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Braid Forbes Health Research   (United States)

^d CATHOLIC UNIVERSITY OF AMERICA   (United States)

^e Tyrx Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BACTEREMIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTION; DEFIBRILLATOR; DEVICE INFECTION; DISEASE ASSOCIATION; ENDOCARDITIS; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPTICEMIA; SHOCK;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGICAL PROCEDURES; COSTS AND COST ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MEDICARE; MIDDLE AGED; PATIENT READMISSION; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES;

EID: 81355133434     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.441     Document Type: Article

References (24)

1. Epstein AE, DiMarco JP, Ellenbogen KA, et al.; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device- Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350-e408.
2. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):e391-e479.
3. Baddour LM, Epstein AE, Erickson CC, et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458-477.
4. Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33(4):414-419.
5. Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147 (4):582-586. (Pubitemid 38900441)
6. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49(18):1851-1859. (Pubitemid 46661104)
7. Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; changes to the hospital inpatient prospective payment system for acute care hospitals and fiscal year 2010 rates; and changes to the long-term care hospital prospective payment system and rate years 2010 and 2009 rates. Final rules and interim final rule with comment period. Fed Regist. 2009;74(165):43753-44236.
8. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27. (Pubitemid 128456396)
9. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/ Deyo methods of comorbidity measurement in administrative data. Med Care. 2004;42(4):355-360.
10. Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008;8:12.
11. (HCUP) AfHRaQAHCaUPHCUP Comorbidity Software. Healthcare Cost and Utilization Project (HCUP). December 2010. Agency for Healthcare Research and Quality, Rockville, MD. Comorbidity Software. http://www.hcup-us.ahrq.gov /toolssoftware/comorbidity/comorbidity.jsp#overview. Accessed February 2, 2011.
12. Collett D. Modelling Binary Data. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2003.
13. Hilbe J. Negative Binomial Regression. Cambridge, MA: Cambridge University Press; 2007.
14. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009;2 (2):129-134.
15. Margey R, McCann H, Blake G, et al. Contemporary management of and outcomes from cardiac device related infections. Europace. 2010;12(1):64-70.
16. Tarakji KG, Chan EJ, Cantillon DJ, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm. 2010; 7(8):1043-1047.
17. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006; 48(3):590-591. (Pubitemid 44093958)
18. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353(14):1471-1480. (Pubitemid 41400921)
19. Mark DB, Nelson CL, Anstrom KJ, et al. SCD-HeFT Investigators. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2006;114(2):135-142. (Pubitemid 44420745)
20. Zwanziger J, Hall WJ, Dick AW, et al. The cost effectiveness of implantable cardioverter- defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006;47(11):2310-2318. (Pubitemid 43795065)
21. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med. 2008;23(Suppl 1):13-19. (Pubitemid 350295396)
22. Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg. 1996;111(4):742-752. (Pubitemid 26118856)
23. Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47(12):2493-2497. (Pubitemid 43866387)
24. Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol. 2008;1(4):240-249.